HF006
The percentage of patients with a current diagnosis of heart failure due to left ventricular systolic dysfunction, who are currently treated with a beta-blocker licensed for heart failure
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF 4 | 2011 | 213 | 282 | 75.5% | |
| HF 4 | 2012 | 268 | 349 | 76.8% | |
| HF 4 | 2013 | 328 | 412 | 79.6% | |
| HF004 | 2014 | 143 | 159 | 89.9% | |
| HF004 | 2015 | 160 | 179 | 89.4% | |
| HF004 | 2016 | 220 | 255 | 86.3% | |
| HF004 | 2017 | 256 | 284 | 90.1% | |
| HF004 | 2018 | 249 | 288 | 86.5% | |
| HF004 | 2019 | 271 | 304 | 89.1% | |
| HF004 | 2020 | 246 | 269 | 91.4% | |
| HF006 | 2021 | 469 | 527 | 89.0% | |
| HF006 | 2022 | 557 | 598 | 93.1% | |
| HF006 | 2023 | 615 | 644 | 95.5% |
